Clinical Trial Dataset Analysis - A phase 2a efficacy, safety and tolerability study
Clinical Trial Dataset Analysis - A phase 2a efficacy, safety and tolerability study on treating patients with schizophrenia
top of page
Darren Wogman MSc
123-456-7890
Search
A target product profile (TPP) for ATL-104. Use in Oral Mucositis (OM). Darren Wogman MSc
A target product profile (TPP) for ATL-104. Use in Oral Mucositis (OM). Darren Wogman MSc
Clinical pharmacology support studies routinely required for IMP registration.
Clinical pharmacology support studies routinely required for IMP registration. SmPCs, ABA, FDI, ADME, QT, Renal, Hepatic, PopPK, DDI, BE
PK/PD Data Analysis - Macrolide Antibiotic
PK/PD Data Analysis - Macrolide Antibiotic. Original Dataset not included. Appendices not included.
The pharmacological evidence required to justify clinical development of a drug candidate
The pharmacological evidence required to justify clinical development of a drug candidate for depression | Darren Wogman
Novel Drug Formulation for a combination antihypertensive in those with swallowing difficulties
Novel Drug Formulation for a combination antihypertensive in those with swallowing difficulties. ACEI 20mg + Thiazide diuretic 25mg
Research Pieces: Blog2
bottom of page